|
WO2017177073A1
|
|
Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use
|
|
WO2017176596A1
|
|
Multivalent vaccines for rabies virus and coronaviruses
|
|
WO2017139758A1
|
|
Rna/dna hybrid nanoparticles modified with single stranded rna toeholds and uses thereof
|
|
WO2017132502A1
|
|
Device and method for detection of counterfeit pharmaceuticals
|
|
US2016251276A1
|
|
Agonist/antagonist compositions and methods of use
|
|
WO2017082924A1
|
|
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
|
|
CN106559986A
|
|
Multivalence influenza virus-like particles (VLP) and its purposes as vaccine
|
|
US2016274004A1
|
|
Adapter for suspending a cryovial over a centrifuge tube
|
|
US2015203842A1
|
|
Co-transcriptional assembly of modified RNA nanoparticles
|
|
EP2885425A1
|
|
Expression of protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer
|
